Carl Turesson
Lund University
192 Papers
588 Citations
Carl Turesson is an academic researcher from Lund University. The author has contributed to research in topics: Rheumatoid arthritis & Medicine. The author has an hindex of 45, co-authored 158 publications. Previous affiliations of Carl Turesson include Malmö University & Mayo Clinic.
Chat about Author
Papers
Pos0630 comparison of the efficacy and safety of original and biosimilar adalimumab molecules in childhood rheumatic diseases
Jan-Åke Nilsson,Saedis Saevarsdottir,Carl Turesson +2 more
TL;DR: This non-interventional, retrospective, single-centre analysis carried out in Umraniye Training and Resrach Hospital, Pediatric Rheumatology Clinic, Istanbul, Turkey, aimed to compare the efficacy and safety of the original and biosimilar adalimumab (ABP-501) molecules in childhood rheumatic diseases.
High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritis
Britt-Marie Nyhäll-Wåhlin,Ingemar F Petersson,Jan-Åke Nilsson,Lennart T. H. Jacobsson,Carl Turesson +4 more
TL;DR: High levels of disease activity and disability during the first 2 years after RA diagnosis, smoking and RF predict the development of severe extra-articular RA.
Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study.
Delphine S. Courvoisier,Deshire Alpizar-Rodriguez,J.-E. Gottenberg,Maria Victoria Hernández,Florenzo Iannone,Elisabeth Lie,Maria José Santos,Karel Pavelka,Carl Turesson,Xavier Mariette,Denis Choquette,Merete Lund Hetland,Axel Finckh +12 more
TL;DR: Clinical information and baseline clinical characteristics do not allow a reliable prediction of which trajectory the patients will follow after bDMARD initiation, and EULAR good or moderate responses at 1 year was much higher among ‘rapid responders’ than among inadequate responders.
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
Pierre Geborek,Anna Bladström,Carl Turesson,Anders Gülfe,Ingemar F Petersson,Tore Saxne,Håkan Olsson,Lennart T H Jacobsson +7 more
TL;DR: Community based patients with RA treated conventionally had an increased overall tumour risk compared with the background population and a possible additional increased risk for lymphoma associated with TNF blockers was based on few cases.
Decrease in the incidence of total hip arthroplasties in patients with rheumatoid arthritis - results from a well defined population in south Sweden
Korosh Hekmat,Lennart T H Jacobsson,Jan-Åke Nilsson,Ingemar F Petersson,Otto Robertsson,Göran Garellick,Carl Turesson +6 more
TL;DR: This investigation shows a significant decrease in the incidence of total hip arthroplasties in patients with RA after 2001, and possible explanations include a positive effect on joint damage from more aggressive pharmacological treatment.